Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Patients without commercial coverage or whose plans exclude anti-obesity medications face the full list price
Others are developing medicines that are longer-acting than those from Novo Nordisk and Lilly
Trial Data Sparks Interest: Phase 3 results for retatrutide reveal substantial weight reductions up to 28 percent at higher doses, with many participants achieving outcomes comparable to surgical interventions
PlexusDx compounded semaglutide reduces this to $1,788$3,468 yearly, depending on your formulation and commitment tier, with transparent flat-rate pricing that doesn't increase with dose adjustments
US$ 23.14
US$ 25.77
US$ 21.84
US$ 25.30
US$ 28.58
US$ 23.82
US$ 26.87
US$ 23.17
US$ 27.24
US$ 22.10
